|
| 36915208 | Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma. | Genome Med | 2023 |
| 37446091 | Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases. | Int J Mol Sci | 2023 |
| 34207911 | Semi-Automated Cell Panning for Efficient Isolation of FGFR3-Targeting Antibody. | Int J Mol Sci | 2021 |
| 33801023 | Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. | Nutrients | 2021 |
| 34724162 | Development of a new advanced animal cradle for small animal multiple imaging modalities: acquisition and evaluation of high-throughput multiple-mouse imaging. | Phys Eng Sci Med | 2021 |
| 32214402 | Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease. | PLoS One | 2020 |
| 33073104 | cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody-Drug Conjugate Targeting c-Met Overexpression Tumors. | ACS Omega | 2020 |
| 29129044 | Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth. | Cancer Res Treat | 2018 |
| 30068070 | Innovative Distribution Priorities for the Medical Devices Industry in the Fourth Industrial Revolution. | Int Neurourol J | 2018 |
| 30262818 | Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. | Nat Genet | 2018 |
| 29715102 | Pharmacokinetics, Biodistribution, and Toxicity Evaluation of Anti-SEMA3A (F11) in <i>In Vivo</i> Models. | Anticancer Res | 2018 |
| 28917835 | Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody. | Biochem Biophys Res Commun | 2017 |
| 28902178 | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain. | Int J Mol Sci | 2017 |
| 26032834 | USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance. | Neuro Oncol | 2016 |
| 26586721 | GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands. | Mol Cancer Ther | 2016 |
| 26023737 | In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma. | Oncotarget | 2015 |
| 26373279 | Spatiotemporal Evolution of the Primary Glioblastoma Genome. | Cancer Cell | 2015 |
| 26704632 | Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain. | BMC Cancer | 2015 |
| 24825439 | Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection. | Eur J Immunol | 2014 |
| 25364264 | Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling. | Onco Targets Ther | 2014 |
| 25180060 | Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model. | Transl Oncol | 2014 |
| 25084005 | Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma. | PLoS One | 2014 |
| 23571426 | Immunoglobulin Fc domain fusion to apolipoprotein(a) kringle V significantly prolongs plasma half-life without affecting its anti-angiogenic activity. | Protein Eng Des Sel | 2013 |
| 23922300 | Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. | Clin Cancer Res | 2013 |
| 22051136 | Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. | Vaccine | 2012 |
| 22659101 | Repeated intravenous infusion of human apolipoprotein(a) kringle V is associated with reversible dose-dependent acute tubulointerstitial nephritis without affecting glomerular filtration function. | Toxicol Lett | 2012 |
| 22577348 | Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model. | Neoplasia | 2012 |
| 22427380 | Human apolipoprotein(a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis. | Diabetes | 2012 |
| 21194375 | Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. | Biol Chem | 2011 |
| 22176950 | Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. | Virol J | 2011 |
| 21917729 | Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8. | Cancer Res | 2011 |
| 21132267 | Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling. | Int J Oncol | 2011 |
| 19944666 | Membrane-based hybridization capture of intracellular peptide nucleic acid. | Anal Biochem | 2010 |
| 19017527 | Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice. | Biochem Biophys Res Commun | 2009 |
| 19741152 | Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model. | J Pharmacol Exp Ther | 2009 |
| 19324960 | Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus. | RNA | 2009 |
| 19446184 | Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. | Vaccine | 2009 |
| 19155084 | Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. | J Hepatol | 2009 |
| 16381001 | Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. | Int J Cancer | 2006 |
| 16628632 | Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice. | Hepatology | 2006 |
| 15517541 | Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. | J Gene Med | 2005 |
| 15932276 | Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element. | Biotechnol Prog | 2005 |
| 14697222 | Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. | Biochem Biophys Res Commun | 2004 |
| 15466205 | Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles. | Cancer Res | 2004 |
| 14711493 | Improved recombinant gene expression in CHO cells using matrix attachment regions. | J Biotechnol | 2004 |
| 14996836 | A truncated kringle domain of human apolipoprotein(a) inhibits the activation of extracellular signal-regulated kinase 1 and 2 through a tyrosine phosphatase-dependent pathway. | J Biol Chem | 2004 |
| 12746434 | Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). | J Biol Chem | 2003 |
| 14524728 | Improved mammalian expression systems by manipulating transcriptional termination regions. | Biotechnol Prog | 2003 |
| 12109252 | A Web-based interactive education programme on vaccination for public health officials. | Asia Pac J Public Health | 2001 |
| 9509415 | Insulin has a limited effect on the cell cycle progression in 3T3 L1 fibroblasts. | Mol Cells | 1997 |